Evidence map›Paper›PMID 41493946›Full record

ArticleJMIR AI2026

Performance of a Small Language Model Versus a Large Language Model in Answering Glaucoma Frequently Asked Patient Questions: Development and Usability Study.

Adriano Cypriano Faneli, Rafael Scherer, Rohit Muralidhar, Marcus Guerreiro-Filho, Luiz Beniz, Verônica Vilasboas-Campos, Douglas Costa, Alessandro A Jammal, Felipe A Medeiros

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adriano Cypriano FaneliBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0001-8834-2600
Rafael SchererBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0002-0322-7900
Rohit MuralidharBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0009-0005-9668-2230
Marcus Guerreiro-FilhoBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0002-4683-5519
Luiz BenizBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0002-3230-5365
Verônica Vilasboas-CamposBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0009-0006-3057-8972
Douglas CostaBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0002-9156-3196
Alessandro A JammalBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0001-5341-8353
Felipe A MedeirosBascom Palmer Eye Institute, University of Miami, 900 NW 17th St, Miami, FL, 33136, United States, 1 305-326-6000.ORCID http://orcid.org/0000-0003-3924-2720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Large language models (LLMs) have been shown to answer patient questions in ophthalmology similar to human experts. However, concerns remain regarding their use, particularly related to patient privacy and potential inaccuracies that could compromise patient safety. Objective: This study aimed to compare the performance of an LLM in answering frequently asked patient questions about glaucoma with that of a small language model (SLM) trained locally on ophthalmology-specific literature. Methods: We compiled 35 frequently asked questions on glaucoma, categorized into 6 domains, including pathogenesis, risk factors, clinical manifestations, diagnosis, treatment and prevention, and prognosis. Each question was posed to both a SLM using a retrieval-augmented generation framework, trained on ophthalmology-specific literature, and to a LLM (ChatGPT 4.0, OpenAI). Three glaucoma specialists from a single institution independently assessed the answers using a 3-tier accuracy rating scale: poor (score=1), borderline (score=2), and good (score=3). Each answer received a quality score ranging from 3 to 9 points based on the sum of ratings from the 3 graders. Readability grade level was assessed using 4 formulas, such as the Flesch-Kincaid Level, the Gunning Fog Index, the Coleman-Liau Index, and the Simple Measure of Gobbledygook Index. Results: The answers from the SLM demonstrated comparable quality with ChatGPT 4.0, scoring mean 7.9 (SD 1.2) and mean 7.4 (SD 1.5), respectively, out of a total of 9 points (P=.13). The accuracy rating was consistent overall and across all 6 glaucoma care domains. Both models provided answers considered unsuitable for health care-related information, as they were difficult for the average layperson to read. Conclusions: Both models generated accurate content, but the answers were considered challenging for the average layperson to understand, making them unsuitable for health care-related information. Given the specialized SLM's comparable performance to the LLM, its high customization potential, lower cost, and ability to operate locally, it presents a viable option for deploying natural language processing in real-world ophthalmology clinical settings.

Indexed as

ChatGPT4.0glaucomalarge language modelonline health informationsmall language model

Identifiers

PMID41493946
PMCPMC12772937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.